Chipscreen Biosciences: It is expected to have a net loss attributable to the mother of 10.698 billion to 13.726 billion yuan by 2025.

In the evening of January 12, Chifeng Biology announced that it is expected to incur a net loss attributable to shareholders of the listed company of 10.698 billion to 13.726 billion yuan in 2025, which is a change from a profit to a loss compared to the same period last year when it made a profit of 2.018 billion yuan.